Both models highlight a deteriorating fundamental-technical confluence, noting that price has lost the 4h SMA20 and is struggling with a revenue miss, inventory build, and a massive $25 billion capex ramp that pressures free cash flow. They agree that if the stock fails to hold the $378-$383 high-volume node, the path of least resistance is a breakdown through the $362.50 support level toward $345. One model adds that falling RSI, a negative MACD histogram, and declining volume suggest upside momentum is exhausted, making the stock vulnerable to profit-taking and macro risk-off sentiment.
All three models agree that TSLA is stabilizing at a critical support zone near $362.50, with two models highlighting that price remains above the 4h SMA50 and within a high-volume node ($364-$379) conducive to a reflexive rebound. Fundamentally, all models cite the EPS beat and margin improvement as key drivers, while two models emphasize that FSD approval progress in Europe and China provides a live catalyst path for a move toward $400-$409. One model specifically notes that a breakout above the 4h SMA20 at $385.02 could trigger institutional re-entry and short-covering.
TSLA looks like a workable swing short on a retest rather than an aggressive breakdown chase. Price is sitting in a mid-range/value-area zone around the 30-day POC after losing the 4h SMA20, with falling RSI, a negative MACD histogram, and declining volume suggesting upside follow-through is weakening; if the stock retests the $378- $383 high-volume node area and stalls, the path of least resistance is a drift back toward the $362.50 support and potentially below it. Fundamentally, the recent revenue miss, visible inventory build, and sharply higher 2026 capex plan create a setup where execution expectations remain high despite softening demand signals, which can pressure a richly valued stock over the next 1-3 weeks if macro risk appetite stays shaky.
TSLA is sitting in a pullback-to-support / mid-range setup rather than a breakdown: price remains above the major $362.50 support, above the 4h SMA50, and inside the value area near heavy-volume support around the $364- $379 zone. The post-earnings read was mixed but not outright bearish, with EPS and margin improvement offsetting the revenue miss, while near-term FSD approval progress in Europe and planned China expansion preserve a live catalyst path over the next 1-3 weeks. A limit entry closer to support improves actionability for a reflexive rebound back toward the upper value area and then the low- $400s if support holds and macro selling pressure stabilizes.
Tesla is positioned for downside following a revenue miss and growing inventory glut, with price already rejecting the high-volume node at $378.66 and trading below key moving averages. The $25 billion capex ramp pressures near-term free cash flow while demand softens, creating a deteriorating fundamental-technical confluence. We expect price to break through support at $362.50 and target $345, driven by continued profit-taking and sector rotation in a broad risk-off environment.
Tesla is forming a bullish reversal setup near key support at $362.50, with price stabilizing above this level and showing early signs of momentum repair. The recent Q1 earnings beat on EPS and improved automotive gross margins, coupled with progress on FSD approvals in Europe and a potential China rollout, provide fundamental and catalyst-driven upside. With volume stabilizing and the stock trading near a high-volume node at $378.66, a breakout above the 4h SMA20 at $385.02 could trigger short-covering and re-entry from institutional buyers, targeting the $409.28 resistance zone.
TSLA's recent earnings beat and improving automotive gross margins, combined with the potential for further growth in the electric vehicle market and advancements in autonomous driving technology, position the company for a potential upside move. The current price, having pulled back from recent highs, presents an opportunity to enter a long position with a reasonable risk-reward ratio.
TSLA's technical structure shows a breakdown below the 20-day and 50-day SMAs, with a recent rejection at the $409 resistance level. The fundamental backdrop is also concerning, with stretched valuation and declining margins. Given the current market regime and technical exhaustion, a short position is warranted.